1 / 8

Plasmid DNA Manufacturing Market Size Share Trends Forecast 2026

Plasmid DNA Manufacturing Market Report- 2020 Analyses competitive environment such as key players, future trends, growths, challenges and acquisitions in the market.

SANJAYCMI
Download Presentation

Plasmid DNA Manufacturing Market Size Share Trends Forecast 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PLASMID DNA MANUFACTURING MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

  2. REPORT DESCRIPTION Plasmid DNA Manufacturing Market - Overview Global Plasmid DNA Manufacturing Market, by Product Type (High Quality (HQ) Plasmid DNA, GMP Grade Plasmid DNA, and Non-GMP Grade Plasmid DNA), by Application (DNA Vaccines, Gene Therapy, Immunotherapy, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 65.1 million in 2017 and is projected to exhibit a CAGR of 23.7% over the forecast period (2018 – 2026). Increased research and development activity is expected to augment the market growth Key players in the market are focused on research & development, expansion, and collaboration activities in order to enhance their market share. For instance, in January 2019, Sarepta Therapeutics, Inc. and Aldevron announced their collaboration. This collaboration provided Sarepta with Aldevron’s manufacturing slots and capacity for production of GMP grade plasmid for its various programs related to gene therapy. For instance, in January 2019, Sarepta Therapeutics, Inc. collaborated with Aldevron to supply GMP grade plasmids, in order to cater to the demand of Sarepta’s gene therapy clinical trials and for commercial supply. Moreover, in April 2018, PlasmidFactory GmbH & Co. KG announced the acquisition of new laboratory space to expand research and development activities and production of plasmid DNA. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/plasmid- dna-manufacturing-market-2593 © Coherent market Insights. All Rights Reserved

  3. REPORT DESCRIPTION Browse 36 Market Data Tables and 32 Figures spread through 149 Pages and in- depth TOC on ‘Plasmid DNA Manufacturing Market’- Global Forecast to 2026, by Product Type (High Quality (HQ) Plasmid DNA, GMP Grade Plasmid DNA, and Non- GMP Grade Plasmid DNA), by Application (DNA Vaccines, Gene Therapy, Immunotherapy, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Key players in the market are focused on adopting strategies such as mergers and acquisitions to enhance their product portfolio. For instance, in February 2016, Agilis Biotherapeutics, LLC (Agilis) and Waisman Biomanufacturing entered into an exclusive partnership agreement for the production of Agilis’ novel gene therapy product, AGIL-FA, for the treatment of Friedreich’s ataxia (FA). Similarly, in March 2019, Aldevron announced expansion plan for antibody development platform facility in Germany. This expansion plan will add around 4,300 square feet of production and laboratory space to current facility. This strategic move was taken, owing to increasing demand for High Quality (HQ) Grade DNA production. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/2593 © Coherent market Insights. All Rights Reserved

  4. REPORT DESCRIPTION Key Takeaways of the Plasmid DNA Manufacturing Market: The global plasmid DNA manufacturing market is expected to exhibit a CAGR of 23.7% over the forecast period, owing to increasing demand for plasmid (pDNA) DNA Among product type, the high quality plasmid DNA segment held dominant position in the plasmid DNA manufacturing market in 2017, owing to increased usage of higher quality plasmid DNA in biotechnology research and vaccine production Among application, immunotherapy segment held dominant position in the plasmid DNA manufacturing market in 2017, owing to high adoption rate of immunotherapy Key players operating in the global plasmid DNA manufacturing market include Cobra Biologics and Pharmaceutical Services, VGXI, Inc., Aldevron, Kaneka Corporation, Nature Technology Corporation, PlasmidFactory GmbH & Co. KG, Cell and Gene Therapy Catapult, and Waisman Biomanufacturing Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/2593 © Coherent market Insights. All Rights Reserved

  5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

  6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

  7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

  8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved

More Related